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Objectives: To determine if histopathologic assessment of esophageal biopsies harvested 
for research study is justiﬁ  ed due to the heterogeneity of tissues in the esophagus, and the 
consequent histopathologic mis-matches with the clinical histopathology of biopsies taken at 
the same level.
Methods: Since 2004, patients undergoing upper endoscopy for a variety of clinical conditions 
were invited to provide additional esophageal biopsies; those were collected for research purpose 
at the same level as biopsies collected for clinical histopathology. Research biopsies were cut in 
two parts: one part was submitted to research histopathology and the other stored for molecular 
analysis. Results of clinical histopathology for each patient were summarized per biopsy level 
and compared to results obtained from research biopsies at the corresponding level.
Results: A total of 377 level summaries were obtained from 137 patients. Clinical histopa-
thology summaries classiﬁ  ed 123 levels (32.6%) as squamous epithelium, 84 levels (22.3%) 
as metaplastic columnar-lined epithelium, 135 levels (35.8%) as columnar-lined epithelium 
with intestinal metaplasia, 30 levels (8%) as dysplasia, and 5 levels (1.3%) as adenocarcinoma. 
Research histopathology matched to clinical summaries on 120 of 123 (97.5%) levels for 
squamous epithelium, 52 of 84 (61.9%) for metaplastic columnar-lined epithelium, and 94 of 
135 (69.5%) for columnar-lined epithelium with intestinal metaplasia. There were no matches 
for dysplasia between the groups; however, they agreed on all ﬁ  ve cases of AC. On 59 (70.2%) 
metaplastic columnar-lined epithelium levels and on 62 (46%) columnar-lined epithelium with 
intestinal metaplasia levels, tissue heterogeneity was observed in clinical histopathology, with 
portions of squamous epithelium within the samples. Matches with pure tissue samples in both 
clinical and research histopathology levels were observed on 22 (26.2%) levels of metaplastic 
columnar-lined epithelium and in 55 (40.7%) levels of columnar-lined epithelium with intestinal 
metaplasia.
Conclusions: The high proportion of mismatches and tissue heterogeneity observed, especially 
among columnar-lined epithelium with intestinal metaplasia and dysplasia, points to the necessity 
of determining the histopathology of the research samples to avoid sampling errors during 
molecular studies.
Keywords: esophageal biopsies, endoscopy, columnar-lined epithelium, Barrett’s esophagus
Introduction
In some individuals with chronic gastroesophageal reﬂ  ux disease, the normal esophageal 
squamous epithelium can be replaced with a metaplastic columnar-lined epithelium 
which exhibits intestinal metaplasia. This condition is called Barrett’s esophagus. It 
can predispose to progression to dysplasia, and in some individuals adenocarcinoma 
can arise in this epithelium.1 Currently, endoscopy with biopsy for histopathology is 
the gold standard for diagnosing Barrett’s esophagus, as well as the development of 
dysplasia and carcinoma. However, endoscopy ﬁ  ndings, when compared to histo-
pathologic diagnosis, have a sensitivity of only 82% and a positive predictive value of Clinical and Experimental Gastroenterology 2009:2 2
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34% for diagnosing columnar-lined epithelium with intestinal 
metaplasia. In part this might be related to focal distribution 
of intestinal metaplasia within columnar-lined epithelium due 
to heterogeneity of tissue types in the esophageal mucosa.2 In 
addition, the identiﬁ  cation of dysplasia is based on subjective 
histopathologic assessment, and there can be signiﬁ  cant 
intra- and inter-observer variability between histopathologists 
when determining the presence of dysplastic changes.3–5 This 
highlights the need for new tools for the detection and follow 
up of various esophageal pathologies.6,7
Advances brought by high-throughput gene expression 
have made it possible to analyze the molecular characteristics 
of normal and abnormal tissues, including esophageal 
pathologies.8–11 The development of tissue biomarkers which 
correctly identify and the risk of progression to dysplasia and 
cancer would be of value for guiding clinical surveillance and 
early diagnosis of high risk lesions. This might facilitate more 
effective and timely therapy. Hence, research in this area 
might impact on future clinical practice if useful biomarkers 
can be identiﬁ  ed.
However, to accurately identify speciﬁ  c biomarkers, it 
is necessary to be certain about the tissue type from which 
nucleic acids are extracted for biomarker discovery studies. 
Unfortunately, the heterogeneity of tissue types within 
the esophageal mucosa in patients who have developed 
Barrett’s esophagus complicates the identification of 
speciﬁ  c mucosal subtypes, and relying on collecting one 
biopsy for histopathology and an adjacent biopsy for nucleic 
acid extraction for research might lead to errors as adjacent 
tissue biopsies in such an individual may contain different 
pathologies.
With the aim of ensuring correct tissue classiﬁ  cation for 
esophageal biopsy samples selected for subsequent molecular 
analysis and research, we developed a technique to identify 
tissue types. This entailed dividing stored biopsy samples 
into two pieces: one for histopathology, and the other for 
molecular study. In this study we determined the accuracy 
and utility of this method for classiﬁ  cation of these tissue 
samples, and compared the outcomes with conventional 
histopathology assessment of biopsies obtained for clinical 
purposes from adjacent mucosa.
Materials and methods
Since 2004, patients undergoing upper gastrointestinal 
endoscopy for a variety of clinical conditions have been 
invited to provide additional endoscopic biopsy samples for 
laboratory research. Biopsies were collected for both clinical 
histopathology and research purposes. In individuals who 
had suspected Barrett’s esophagus, the biopsy collection 
protocol entailed the collection of a mucosal biopsy from 
four quadrants of the esophageal wall, 1 cm above the 
gastroesophageal junction, and then every 2 cm proximally 
for the full length of the columnar mucosa. These biopsy 
samples were placed in formalin and sent for conventional 
histopathology for clinical diagnostic purposes. A further 
three mucosal biopsies were obtained from the same levels 
in the esophagus, and three biopsies were also collected 
from the proximal stomach, and three from the proximal 
squamous epithelium, 5 cm above the upper limit of the 
columnar epithelium. These biopsy samples were processed 
for laboratory research as described below.
In individuals with suspected cancer, sufﬁ  cient biopsies 
of the cancer were collected, placed in formalin and sent 
for conventional histopathologic assessment. Three to four 
extra biopsy samples were collected from the tumor for 
research purposes, as well as three biopsies from the proximal 
stomach, and three from the proximal squamous epithelium. 
In all other individuals three biopsies were also collected 
from the proximal stomach for research purposes, three from 
the esophageal squamous epithelium 2 cm proximal to the 
gastroesophageal junction and three from 8 cm more proximal. 
Some variation in the tissue collection protocol occurred 
according to clinical ﬁ  ndings (eg, mucosal ulceration, and the 
presence of islands or tongues of columnar-lined epithelium 
with suspected intestinal metaplasia).
All biopsies collected for research were immediately 
placed in RNA-later® and stored at –20 °C until required 
for later study. When removed from storage, biopsies were 
thawed, and a small piece which comprised approximately 
20% to 30% of each biopsy was cut off with a scalpel blade 
and placed in formalin. This piece was then embedded in 
parafﬁ  n, sliced and stained with hematoxylin and eosin, as 
well as ABPAS/D histochemical stain, and then examined 
using conventional light microscopy. The remainder of the 
biopsy was then stored at –80 °C for later nucleic acid extrac-
tion and molecular studies.
The histopathology slides prepared from the fragments 
of the research biopsy samples where examined by a single 
pathologist (DA) with expertise in esophageal pathology. The 
pathologist was unaware of the results of any conventional 
histopathology analysis of biopsy samples collected for clini-
cal purposes from the same individuals. Intestinal metaplasia 
within columnar epithelium was conﬁ  rmed by the presence 
of goblet cells, which were identiﬁ  ed using ABPAS/D histo-
chemical staining. The presence of dysplasia in any clinical 
biopsy samples was also determined.Clinical and Experimental Gastroenterology 2009:2 3
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To assess the tissue type identiﬁ  ed in the fragments of the 
research biopsies, we compared the diagnosis from biopsies 
collected for clinical histopathology with that for the histo-
pathology from the research biopsy fragments, when both 
types of biopsy were obtained from the equivalent level in the 
esophagus; ie, the same distance from the gastroesophageal 
junction. In addition, to assess inter- and intra-observer 
variability, all slides from clinical samples reported to contain 
dysplastic tissues, and the corresponding slides from research 
samples were reviewed again by the pathologist. For this 
analysis the pathologist was blinded to the ﬁ  rst diagnosis. 
Representative sections of each tissue type from matched 
clinical and research biopsies are shown in Figure 1.
The tissue collection for this study was approved by the 
Flinders Clinical Research Ethics Committee and the Repatria-
tion General Hospital Clinical Research Ethics Committee.
Results
One hundred thirty-seven individuals were included in 
this study, and endoscopic biopsies were obtained from 
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Figure 1 Sections of esophageal epithelium from matched research and clinical biopsies from the esophagus. Research biopsy sections are shown on the left panel and the 
matched clinical biopsy sections are on the right panel. A–F are sections stained with ABPAS/D. G–L are sections stained with H&E. A and B show stratiﬁ  ed squamous 
epithelium, C and D show columnar lined epithelium without intestinal metaplasia, E and F show columnar-lined epithelium with intestinal metaplasia, G and H show changes 
consistent with low grade dysplasia, I and J represent carcinoma in-situ, and K and L show invasive cancer.Clinical and Experimental Gastroenterology 2009:2 4
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377 different levels (or sites). Clinical histopathology 
identified 123 levels (32.6%) as squamous epithelium, 
84 levels (22.3%) as columnar epithelium without intestinal 
metaplasia, 135 levels (35.8%) as columnar epithelium with 
intestinal metaplasia, 30 levels (8%) as dysplasia (28, low 
grade dysplasia; 2, high grade dysplasia), and 5 levels (1.3%) 
as adenocarcinoma.
Two hundred seventy-one (71.9 %) of the diagnoses 
made by histopathology assessment of the research 
biopsy fragments, matched the clinical histopathology 
assessment, and in 108 (28.1%) the assessment differed 
(Figure 2). The proportion of matches between assessment 
from corresponding research and clinical biopsies varied 
according to the pathological classiﬁ  cation. There was a 
high level of concordance for squamous epithelium and 
adenocarcinoma, with all but three squamous epithelium 
and all adenocarcinoma research biopsies matching 
the classiﬁ  cation of adjacent clinical samples. However, 
the tissue type identiﬁ  ed in the clinical biopsies matched 
the type identiﬁ  ed in the research biopsy fragments in only 
52 of 84 (61.9%) columnar epithelium without intestinal 
metaplasia samples, and 94 of 135 (69.6%) the columnar 
epithelium with intestinal metaplasia samples (Figure 2). 
Differences usually occurred when columnar epithelium 
without intestinal metaplasia was identiﬁ  ed in one sample, 
and columnar epithelium with intestinal metaplasia in the 
matched samples, and vice versa.
Heterogeneity within individual biopsy samples was 
identiﬁ  ed when a portion of squamous epithelium was found 
alongside columnar epithelium with or without intestinal 
metaplasia, within the same biopsy sample. Although het-
erogeneity was observed in only 30 (7.6%) of the research 
biopsies, review of histopathology from the clinical biopsies 
showed a higher prevalence of heterogeneity in the clinical 
biopsy samples, 121 (32%). This might be due the larger 
size of the clinical biopsy samples, compared to the research 
samples, which were all split for histopathology and nucleic 
acid extraction. Matches where only one tissue type was 
observed in both clinical histopathology and research his-
topathology, were reported on 22 of 84 (26.2%) levels of 
metaplastic columnar-lined epithelium and in 55 of 135 
(40.7%) levels of columnar-lined epithelium with intestinal 
metaplasia.
When research biopsy samples were obtained from areas 
adjacent to squamous mucosa identiﬁ  ed by clinical histo-
pathology, 120 (97.5%) research biopsies contained only 
squamous epithelium. In two biopsies (1.6%), research histo-
pathology contained portions of columnar epithelium within 
squamous epithelium, and in one (0.9%) only columnar 
epithelium was identiﬁ  ed.
On the 84 esophageal levels which contained metaplastic 
columnar epithelium without intestinal metaplasia on 
clinical histopathology assessment, 59 (70.2%) also had 
portions of squamous epithelium in at least one of the 
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Figure 2 Number of matches and mismatches between histopathology for research biopsy vs. clinical biopsy. The type of tissue present in the clinical biopsy is named on 
the X axis.
Notes: The number of biopsies for which there was a perfect match between clinical and research histopathology is shown above the ‘matches’ column. The number of biopsies 
for which there was a partial mis-match (ie, some degree of heterogeneity of tissue types) or a complete mismatch (ie, no commonality in tissue types) between clinical and 
research histopathology is shown above the ‘mismatches’ column.
Abbreviations:  AC, adenocarcinoma; CLE, columnar-lined epithelium; D, dysplasia; IM, columnar-lined epithelium with intestinal metaplasia; SE, squamous epithelium.Clinical and Experimental Gastroenterology 2009:2 5
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clinical biopsies. The histopathology ﬁ  ndings from the 
research samples from the same level were identical in 
52 (61.9%), whereas only squamous epithelium was iden-
tiﬁ  ed in 22 biopsies (26.2%), and intestinal metaplasia 
within columnar epithelium in another 10 biopsies (11.9%). 
Histopathology identiﬁ  ed columnar epithelium without 
intestinal metaplasia in both the research and clinical biopsy 
samples in 22 (26.2%) cases.
Of the 135 esophageal levels which had columnar 
epithelium with intestinal metaplasia within the clinical biopsy 
samples, there were 62 (46%) levels which also contained 
portions of squamous epithelium. Histopathology from the 
research samples matched these ﬁ  ndings in 94 (69.5%) 
biopsies. In eight (6%) biopsies only squamous epithelium 
was identiﬁ  ed, in 29 (21.5%) only columnar epithelium 
without intestinal metaplasia, in two (1.5%) both squamous 
epithelium and columnar epithelium without intestinal 
metaplasia, and dysplasia was identiﬁ  ed in two (1.5%).
There were few matches between the clinical and 
research pathology diagnoses for dysplasia. Of 30 clinical 
levels which had dysplasia in at least one of the four clinical 
biopsies (28, low grade dysplasia; 2, high grade dysplasia), 
the corresponding histopathology from the research biopsy 
fragment was columnar epithelium without intestinal 
metaplasia in nine (30%), columnar-lined epithelium with 
intestinal metaplasia in another 19 (63%), and low grade 
dysplasia in two (7%). The histopathology from the research 
biopsy fragments and the clinical biopsies matched in all ﬁ  ve 
cases of adenocarcinoma.
Discussion
In this study we determined the proportion of matches between 
tissue types identiﬁ  ed by histopathologic examination of 
fragments of esophageal mucosal biopsies collected for 
research purposes vs esophageal mucosal biopsies collected 
for clinical diagnosis. For clinical purposes, at each level 
multiple biopsies were usually collected from different 
aspects of the esophageal wall, and if Barrett’s esophagus 
was suspected clinically, four biopsies were collected at 
each level, one from each quadrant, using the Seattle biopsy 
collection protocol.12 This meant that more than one biopsy 
sample was usually obtained for clinical diagnosis from 
appropriate levels within the esophagus. These biopsies 
were usually reported as a summary for each esophageal 
level rather than per biopsy, and this meant that in some 
individuals more than one tissue type was present at each 
esophageal level, whereas in others up to four biopsies from 
a level all identiﬁ  ed a single tissue type.
When undertaking molecular biology research which 
seeks to identify changes in gene expression and other related 
changes within esophageal mucosal cells, it is important to 
accurately identify the mucosal tissue type from which nucleic 
acids are extracted. Whilst this might be done using laser 
capture microdissection, this technology is not suitable for the 
analysis of whole fresh esophageal biopsy specimens, and other 
strategies need to be considered. One option is to collect fresh 
tissue biopsies for research from the same level as biopsies that 
are collected for clinical diagnostic purposes, and then assume 
that the tissue type contained in the research biopsy is identical 
to that identiﬁ  ed by histopathologic examination of the clini-
cal biopsy specimens from the same level. Unfortunately, this 
assumption is not always correct, and the heterogeneity of tis-
sue types found in the distal esophageal mucosa of individuals 
with Barrett’s esophagus means that more accurate identiﬁ  ca-
tion of tissue type is required to avoid the errors which can 
arise if tissues are not correctly classiﬁ  ed.
Table 1 Matches and mismatches between research histopathology results vs. clinical histopathology
Research biopsy histology Clinical biopsy histology
SE CLE IM D AC
with SE no SE with SE no SE
SE 120a 22 0 6 2 0 0
CLE With SE 2 7 1 1 1 2 0
no SE 1 22 22b 18 11 7 0
IM with SE 0 3 1 9 2 1 0
no SE 0 5 1 28 55c 20 0
D0 0 0 0 2 0 0
AC 0 0 0 0 0 0 5
Total 123 59 25 62 73 30 5
Notes: Grey highlighted areas are matches between research and clinical histopathology. aSamples containing only SE; bSamples containing only CLE; csamples containing only IM.
Abbreviations: AC, adenocarcinoma; CLE, columnar-lined epithelium; D, dysplasia; IM, columnar-lined epithelium with intestinal metaplasia; SE, squamous epithelium.Clinical and Experimental Gastroenterology 2009:2 6
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It was because of this problem that we developed the 
described technique of splitting the biopsies collected for 
research, with approximately 30% of the biopsy removed 
for histopathology. This was done to minimize the risk of 
erroneous classiﬁ  cation of each individual biopsy due to 
heterogeneity. For such a method to be valid, however, the 
quality of the histopathology slides needs to be comparable to 
those obtained from conventional histopathology techniques. 
The research specimens were all initially stored and frozen in 
RNA later, then thawed and split before placing a fragment 
into formalin for ﬁ  xation and subsequent embedding in 
parafﬁ  n, slicing, staining, and then examination under light 
microscopy. Our experience conﬁ  rmed that the quality of the 
histopathology slides obtained by this process was good, and it 
allowed accurate assessment of each biopsy. Furthermore, we 
were still able to obtain good yields of DNA and RNA from 
the residual specimen (unpublished data). We have success-
fully used this for microarray and qPCR proﬁ  ling of mRNA 
and microRNA expression in esophageal disease.13,14
Our results showed a high percentage of matches 
between clinical and research histopathology for both 
squamous epithelia and cancer. For squamous epithelia the 
endoscopic visual identiﬁ  cation of the nature of the mucosa 
biopsied is usually accurate, and squamous mucosa is usually 
homogenous. This means that errors in classiﬁ  cation of this 
mucosal type are unlikely to occur. Similarly, for cancer 
endoscopic visual identiﬁ  cation is usually accurate, and 
biopsies can usually be obtained accurately.
On the other hand, a high proportion of mismatches were 
observed for columnar mucosa with versus without intestinal 
metaplasia, and for dysplasia. This highlights the importance 
of accurate identiﬁ  cation of mucosal type, and conﬁ  rms the 
risk of error if researchers rely on taking adjacent, but separate 
biopsies: one for clinical diagnosis and one for research pur-
poses. This problem is partly due to the heterogeneity within 
metaplastic columnar mucosa in individuals with Barrett’s 
esophagus. It can also be due to difﬁ  culties with accurate 
biopsy collection in such individuals. Biopsy collection 
requires accurate manipulation of endoscopic biopsy forceps, 
and this can be difﬁ  cult, particularly in individuals with short 
segments of Barrett’s esophagus, or tongues of metaplastic 
mucosa. Furthermore, as each biopsy is collected, there is 
usually a small amount of bleeding from the biopsy site, 
and this can obscure the endoscopist’s vision, rendering 
accurate collection of the next biopsy more difﬁ  cult. This 
can contribute to errors in tissue identiﬁ  cation, particularly 
when sampling close to the squamo-columnar junction. In 
our study there were a signiﬁ  cant number of individuals in 
whom endoscopy identiﬁ  ed tongues or islands of metaplastic 
columnar mucosa, highlighting this potential problem.
It is also possible, but perhaps less likely, that heterogeneity 
was less common in the research biopsies because they were 
smaller fragments than the clinical biopsies, and hence a 
different tissue might have been found if a different part 
of the research biopsy had been examined pathologically. 
For this reason, complete accuracy of diagnosis cannot be 
guaranteed by the method described, although the extent 
of misdiagnosis of tissues type has almost certainly been 
minimized by this method.
With dysplasia the problem of heterogeneity is also impor-
tant, but in addition, inter-observer variability and subjectivity 
in the diagnosis and grading of dysplasia is likely to have 
further confounded the correct identiﬁ  cation of mucosal type. 
In our study the inter-observer agreement between the original 
clinical diagnosis and the pathologist re-reviewing the 
pathology was 73%, which is in line with previous reports.5 
We found that intra-observer agreement when re-reporting 
the research biopsies was 93%. These ﬁ  ndings reinforce the 
necessity of having access to an experienced pathologist, 
especially when dysplasia is considered. Correct characteriza-
tion and grading of dysplasia is potentially of great beneﬁ  t 
for research which is investigating the progression from 
Barrett’s esophagus to cancer. The identiﬁ  cation of molecular 
biomarkers for normal and abnormal esophageal tissues is 
of considerable interest,10–12 and identiﬁ  cation of consistent 
tissue signatures, in particular for dysplasia, have the potential 
to improve diagnosis and improve management.
We saw a high proportion of heterogeneity within 
different biopsies collected for clinical purposes, and if we 
relied on clinical pathology reports for tissue classiﬁ  cation, 
signiﬁ  cant errors could occur, and gene expression proﬁ  ling 
of supposed esophageal mucosal types may not be correct. 
For this reason, the histopathology analysis of the fragments 
of the research biopsies is likely to minimize the risk of 
misclassiﬁ  cation due to heterogeneity, as well as errors 
in biopsy collection, thereby improving the reliability of 
research data in this ﬁ  eld.
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